BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23806608)

  • 1. Mutation mapping of apolipoprotein A-I structure assisted with the putative cholesterol recognition regions.
    Dergunov AD
    Biochim Biophys Acta; 2013 Oct; 1834(10):2030-5. PubMed ID: 23806608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels.
    Del Giudice R; Domingo-Espín J; Iacobucci I; Nilsson O; Monti M; Monti DM; Lagerstedt JO
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3038-3048. PubMed ID: 28887204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-free Apolipoprotein A-I Structure: Insights into HDL Formation and Atherosclerosis Development.
    Mei X; Atkinson D
    Arch Med Res; 2015 Jul; 46(5):351-60. PubMed ID: 26048453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein A-I configuration and cell cholesterol efflux activity of discoidal lipoproteins depend on the reconstitution process.
    Cuellar LÁ; Prieto ED; Cabaleiro LV; Garda HA
    Biochim Biophys Acta; 2014 Jan; 1841(1):180-9. PubMed ID: 24201377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and stability of apolipoprotein a-I in solution and in discoidal high-density lipoprotein probed by double charge ablation and deletion mutation.
    Gorshkova IN; Liu T; Kan HY; Chroni A; Zannis VI; Atkinson D
    Biochemistry; 2006 Jan; 45(4):1242-54. PubMed ID: 16430220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Lipid-Free and Lipid-Associated ApoA-I in Cellular Cho-lesterol Efflux.
    Dergunov AD; Garaeva EA; Savushkin EV; Litvinov DY
    Curr Protein Pept Sci; 2017; 18(1):92-99. PubMed ID: 27412400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation.
    Sorci-Thomas MG; Curtiss L; Parks JS; Thomas MJ; Kearns MW; Landrum M
    J Biol Chem; 1998 May; 273(19):11776-82. PubMed ID: 9565601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.
    Gursky O; Mei X; Atkinson D
    Biochemistry; 2012 Jan; 51(1):10-8. PubMed ID: 22229410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant.
    Dalla-Riva J; Lagerstedt JO; Petrlova J
    PLoS One; 2015; 10(11):e0143915. PubMed ID: 26605794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I: structure-function relationships.
    Frank PG; Marcel YL
    J Lipid Res; 2000 Jun; 41(6):853-72. PubMed ID: 10828078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.
    Das M; Mei X; Jayaraman S; Atkinson D; Gursky O
    FEBS J; 2014 Jun; 281(11):2525-42. PubMed ID: 24702826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of lipid-free apolipoprotein A-I with cholesterol revealed by molecular modeling.
    Baserova VB; Dergunov AD
    Biochim Biophys Acta Proteins Proteom; 2021 May; 1869(5):140614. PubMed ID: 33548491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of altered apolipoprotein A-I structure on plasma HDL concentration.
    Sorci-Thomas MG; Thomas MJ
    Trends Cardiovasc Med; 2002 Apr; 12(3):121-8. PubMed ID: 12007737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
    Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
    Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchrotron radiation circular dichroism spectroscopy reveals structural divergences in HDL-bound apoA-I variants.
    Giudice RD; Nilsson O; Domingo-Espín J; Lagerstedt JO
    Sci Rep; 2017 Oct; 7(1):13540. PubMed ID: 29051568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and structural ramifications of a hinge domain in apolipoprotein A-I discoidal high-density lipoproteins of different size.
    Maiorano JN; Jandacek RJ; Horace EM; Davidson WS
    Biochemistry; 2004 Sep; 43(37):11717-26. PubMed ID: 15362856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural studies of discoidal lipoprotein A-I.
    Koppaka V
    Cell Mol Life Sci; 2001 Jun; 58(7):885-93. PubMed ID: 11497237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformation and lipid binding of a C-terminal (198-243) peptide of human apolipoprotein A-I.
    Zhu HL; Atkinson D
    Biochemistry; 2007 Feb; 46(6):1624-34. PubMed ID: 17279626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional basis for increased HDL-cholesterol levels due to the naturally occurring V19L mutation in human apolipoprotein A-I.
    Gkolfinopoulou C; Bourtsala A; Chroni A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Mar; 1865(3):158593. PubMed ID: 31863971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.